A 56-year-old Japanese female simultaneously developed thrombocytopenia, sicca symptoms, and an elevation of transaminase. Antiphospholipid antibodies were detected in her serum. The presence of anti-SS-A antibodies in the serum and sialectasis, disclosed by sialography, suggested the presence of primary Sjogren's syndrome (SjS). The laboratory data and the biopsy of the liver showed compatible findings with autoimmune hepatitis (AIH). Thrombocytopenia and liver dysfunction satisfactorily responded to corticosteroid. To our knowledge, this is the first reported case of SjS with AIH and antiphospholipid antibody syndrome (APAS). Analysis of serum cytokine levels showed a predominance of ThO-Thl response, which is not compatible with AIH, in this complicated autoimmune state. (Internal Medicine 39: 73-76, 2000) 
Introduction
Autoimmunehepatitis (AIH) is a disorder of unknownetiology in which progressive destruction of the hepatic parenchymaoccurs, often progressing to cirrhosis. In severe cases, there is a high mortality rate if untreated (1) . Other autoimmune diseases, such as rheumatoid arthritis, Hashimoto's thyroiditis or Sjogren's syndrome (SjS), often co-exist in AIH patients (1, 2).
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Antiphospholipid antibodies (anticardiolipin antibodies or the lupus anticoagulant) are observed in antiphospholipid antibody syndrome (APAS), which is an autoimmunedisease with clinical features such as thrombosis, fetal loss or thrombocytopenia (3). APASis not a well recognized complication of AIH. Here, we present a case of SjS with AIH and APAS, and describe the balance of cytokines (Thl/Th2) in her serum.
Case Report
A 56-year-old Japanese female, who had an operation for mechanical ileus when she was 46 years old, and had delivered 2 children without fetal loss, was found to have an elevated level of transaminase and thrombocytopenia in June 1998. She felt itchy without skin eruption or xerophthalmia for a few weeks. She was admitted to our hospital in September 1998 for further examination and treatment. Table 1 shows the laboratory data on admission.
Diagnosis of SjS
Schirmer's test was positive. Sialectasis, which was represented by gross distortion of the normal pattern, with marked retention (globular pattern), was observed (Fig. 1) . Anti-nucleated antibody (ANA) with a speckled pattern and anti-SS-A antibody were positive.
Diagnosis of AIH
Hepatosplenomegaly was not observed by computed tomography or ultrasound. The elevation of transaminase was noted, but the y-globulin level was normal. The markers for A, B and C viral hepatitis were all negative. ANAwas positive. No liverkidney microsomal antibody (LKM-1) was detected. Needle biopsy of the liver was performed on day 8 at the beginning of oral prednisolone therapy (30 mg/day), when the number of platelets were increased to 9.6xlO4/|jl Microscopic study revealed the presence of chronic active hepatitis, which was represented by periportal and periseptal piecemeal necrosis, as well as bridging necrosis (Fig. 2 ). However, a lymphoplasmacytic infiltrate was not observed.
Diagnosis of APAS
Splenomegaly was not found. Thrombocytopenia with a high level of platelet-associated IgG (PAIgG) was observed, without anemia or leukocytopenia. Bonemarrowaspirate showed an increase in the number of megakaryocytes, with decreased platelet production around them. Anti-cardiolipin antibody and lupus anticoagulant were detected. These findings were compatible with SjS, AIH and APAS (1, 3, 4) . However, the diagnostic criteria of systemic lupus erythematosus was not fulfilled (5) . The score by the scoring system for diagnosis ofAIH was + 14 before the start of therapy and +17 after liver biopsy, suggesting probable AIH (1). Oral prednisolone was administered at a dose of 30 mg/day. The numberof platelets increased and the level of transaminase decreased rapidly (Fig. 3) . Skin itching subsided 5 days after the start of prednisolone. The dose of prednisolone was tapered and was maintained at 7.5 mg/day. Westudied the cytokine levels in sera of this patient before treatment to analyze the Th l/2 deviation.
Methods and Results
The concentrations of following cytokines in sera of this patient on admission were assayed by enzymelinked immunosorbent assay to determine the immunechanges in cytokine responses: interleukin (IL)-2, IL-3, IL-4, IL-6, IL-10, soluble IL-2 receptor (SIL-2R), SIL-6R, granulocyte-macrophage colony stimulating factor (GM-CSF), and interferon-y (IFN-y). The normal range was determined by mean±2stan-dard deviations from normal controls. High concentrations were observed for SIL-2R, IFN-y and GM-CSF, but not for the other cytokines ( Table 2 ).
Discussion
The score by the scoring system for diagnosis ofAIH after treatment was +19 which suggested definite AIH (1). Although overlapping syndromes, such as AIH with primary biliary cirrhosis, primary sclerosing hepatitis or Wilson's disease, have been reported, laboratory findings and biopsy specimen of the liver confirmed that this case was not an overlapping syndrome (1) . Recently, a nationwide survey ofAIH was carried out in Japan (2) . The clinical features of Japanese AIH were as follows: most patients were middle-aged women,serum autoantibodies, especially ANA, were frequently positive, serum IgG level was high, and HLA-DR4was the major HLAallotype.
Ninety-two percent of the patients showed piecemeal necrosis, and 60% bridging necrosis. Plasma cell infiltration in the portal areas was observed in 50%of the patients. A favorable effect of corticosteroid was observed in 89%of the patients. In the present case, although some features were not compatible with Japanese AIH, such as HLAallotype and serum IgG level, we regarded this case as AIHbased on other factors. in our patient. Other symptomsofAPAS, such as miscarriage or thrombosis, were not present, and a high level of SIL-2R is considered as an index of severity of classical idiopathic thrombocytopenic purpura (ITP) (6) . Interestingly, antiphospholipid antibodies have been found in up to 30% of the patients with ITP (7). However, we regarded this case as APASin a broad sense because of autoimmunethrombocytopenia and based on the presence of antiphospholipid antibodies. Wethink that concomitant SjS, AIH and APASis a very rare phenomenonbecause the abnormality of immunesystem in these disorders must not be common.Wetried to analyze the immunedeviation by the evaluation of serum cytokines. The cytokine levels in sera of this patient showed a predominant level of ThO-Thl , because of the increased concentrations of IFN-y and insignificance of IL-4 (8). These results are compatible with the findings of some autoimmunediseases, such as autoimmune thrombocytopenia and SjS (9, 10). However, Lohr et al reported that T cells from some patients with AIH show a high secretion of IL-4 and IL-10, which are representative cytokines of a Th2 response (ll) . It is possible that T cells in the peripheral circulation were associated with autoimmune thrombocytopenia and were Thl, and those in the liver were associated with AIH and were Th2. In conclusion, AIHshould be considered as one of the complications in APAS, as well as SjS, when the liver function is abnormal. Further analysis of the cytokine network for T cell regulation is needed to understand the mechanismof these complicated autoimmunediseases.
